Abdominal Body Contouring After Bariatric, Pharmacological, and Combined Weight Loss: A Narrative Review and Clinical Decision Framework
Journal of Clinical Medicine · 11.11.2026 · 15 (22) · 8828
DOI: 10.3390/jcm15228828 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 11.11.2026. Verfasst von Feliciano Ciccarelli und 7 weiteren Autor:innen. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Abdominal body contouring after substantial weight loss increasingly involves patients treated by bariatric surgery, incretin-based pharmacotherapy, or both. This focused narrative review updates surgical planning across these trajectories, with emphasis on timing, nutritional and hematological preparation, procedure selection, perioperative incretin management, complications, and patient-reported outcomes. The original structured PubMed searches were supplemented during revision by a focused screen of comparative incretin/body-contouring studies and primary perioperative aspiration studies through 24 October 2026. Comparative body-contouring evidence remains observational and heterogeneous: some cohorts report no independent modality effect, whereas others associate GLP-1 receptor agonist exposure, rapid weight loss, or combined treatment with selected wound complications. Two recent meta-analyses similarly identify limited and inconsistent signals rather than a uniform risk pattern. Gastric-ultrasound studies demonstrate more residual gastric content in semaglutide users, but clinical aspiration data are conflicting, supporting individualized anesthetic assessment rather than a universal interruption interval. Practical assessment should integrate weight trajectory, achieved intake, anemia and micronutrient risk, anatomical deformity, psychological readiness, venous-thromboembolism risk, abdominal-wall pathology, and the cumulative recovery burden of combined procedures. Comparative evidence supports dead-space reduction and consideration of Scarpa fascia preservation for seroma prevention. A proposed decision framework distinguishes evidence from professional guidance and review-derived clinical judgment. The framework is not a validated prediction instrument and requires prospective evaluation.
Zitieren
APA
Ciccarelli, F., Moccia, F., Vastarella, M. G., Vastarella, C., Vastarella, V., Amoroso, A., Cuomo, R., & Pieretti, G. (2026). Abdominal Body Contouring After Bariatric, Pharmacological, and Combined Weight Loss: A Narrative Review and Clinical Decision Framework. Journal of Clinical Medicine, 15(22), 8828. https://doi.org/10.3390/jcm15228828
Vancouver
Ciccarelli F, Moccia F, Vastarella MG, Vastarella C, Vastarella V, Amoroso A, et al. Abdominal Body Contouring After Bariatric, Pharmacological, and Combined Weight Loss: A Narrative Review and Clinical Decision Framework. Journal of Clinical Medicine. 2026;15(22):8828. doi:10.3390/jcm15228828
BibTeX
@article{Ciccarelli2026,
author = {Ciccarelli, Feliciano and Moccia, Felice and Vastarella, Maria Giovanna and Vastarella, Claudia and Vastarella, Vincenzo and Amoroso, Arturo and Cuomo, Roberto and Pieretti, Gorizio},
title = {Abdominal Body Contouring After Bariatric, Pharmacological, and Combined Weight Loss: A Narrative Review and Clinical Decision Framework},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {22},
pages = {8828},
doi = {10.3390/jcm15228828}
}
EUVIMED